Editorial: Agency in denial - Stem cell board lacks money, not issues [California]
By Sacramento Bee,
Sacramento Bee
| 08. 13. 2005
People who suffer a serious medical setback often can't come to grips with it. Paralyzed stroke victims, for instance, sometimes insist they can raise their arms when they can't.
Doctors call this disorder "denial syndrome". California's $3 billion stem cell research institute appears to be afflicted by it.
Lawsuits filed by opponents of embryonic stem cell research have prevented the state from issuing bonds for the Institute for Regenerative Medicine, putting the whole program in limbo. These lawsuits are hugely dispiriting to Californians who support stem cell research, but they are a reality, and they could delay the institute's research grants by one or two years.
Institute leaders need to make the most of this lull by settling issues that will continue to dog the institute over the next decade. Instead, Institute Chairman Robert Klein II continues to toot his horn and cry "full steam ahead!" even as his ship remains tethered to the dock.
The latest exercise in institutional denial came Aug. 3 in San Francisco, where the institute held the first meeting of its grants review committee. The...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...